Alnylam Pharmaceuticals
ALNY
#592
Rank
A$52.48 B
Marketcap
$405.55
Share price
-5.91%
Change (1 day)
76.63%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company